Skip to Content

Gablofen FDA Approval History

FDA Approved: Yes (First approved November 19, 2010)
Brand name: Gablofen
Generic name: baclofen
Dosage form: Injection
Company: CNS Therapeutics
Treatment for: Cerebral Spasticity, Chronic Spasticity

Gablofen (baclofen) is a gamma-aminobutyric acid (GABA) ergic agonist indicated for use in the management of severe spasticity.

Development Timeline for Gablofen

DateArticle
Nov 23, 2010Approval FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.